Mystic Asset Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-55,500
Closed -$450K 141
2023
Q1
$450K Sell
55,500
-1,000
-2% -$8.03K 0.25% 103
2022
Q4
$355K Sell
56,500
-55,500
-50% -$388K 0.2% 111
2022
Q3
$771K Buy
112,000
+29,925
+36% +$208K 0.49% 67
2022
Q2
$686K Buy
82,075
+40,475
+97% +$566K 0.42% 81
2022
Q1
$950K Buy
41,600
+1,800
+5% +$44K 0.51% 67
2021
Q4
$1.1M Buy
+39,800
New +$1.07M 0.52% 63

Other funds holding BHC

Mystic Asset Management's BHC Position: Q2 2023 in Review

Mystic Asset Management sold out of Bausch Health (BHC) in Q2 2023, closing a stake of 55,500 shares — an estimated $450K sold.

Mystic Asset Management first reported a position in BHC in Q4 2021 and held it in 6 quarters. The position peaked at $1.1M in Q4 2021. 232 funds tracked by Wall St. Rank hold BHC as of Q2 2023.

  • Mystic Asset Management reported no remaining Bausch Health position as of Q2 2023 after selling out during the quarter.
  • Mystic Asset Management sold 55,500 Bausch Health shares in Q2 2023, an estimated $450K.
  • Mystic Asset Management first reported a position in Bausch Health in Q4 2021 and held it in 6 quarters.
  • Mystic Asset Management's Bausch Health position peaked at $1.1M in Q4 2021.
  • 232 funds tracked by Wall St. Rank held Bausch Health as of Q2 2023.

Based on Mystic Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.